The cardiac endothelin system in established pressure overload left ventricular hypertrophy

被引:25
作者
Schunkert, H [1 ]
Orzechowski, HD
Böcker, W
Meier, R
Riegger, GAJ
Paul, M
机构
[1] Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany
[2] Free Univ Berlin, Inst Clin Pharmacol & Toxicol, Benjamin Franklin Med Ctr, Berlin, Germany
来源
JOURNAL OF MOLECULAR MEDICINE-JMM | 1999年 / 77卷 / 08期
关键词
cardiac hypertrophy; endothelin; endothelin converting enzyme; endothelin receptor;
D O I
10.1007/s001099900035
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In normal hearts, endothelin-1 (ET-1) has been shown to initiate myocyte growth and to modulate cardiac function. However, regulation of the various components of the system and the functional effects of ET-1 in established left ventricular hypertrophy (LVH) are less clear. We thus studied ET-1, ETA receptor, and endothelin converting enzyme (ECE-1) mRNA regulation as well as the effects of ET-1 on coronary resistance, LV contractility and relaxation in hypertrophied rat hearts. Cardiac pressure overload, secondary to banding of the ascending aorta, resulted in a transient increase of cardiac ET-1 and ETA receptor mRNAs that reached a maximum at 2 days (+75% and +40%, respectively, P<0.05, each). ET-1 mRNA levels reached a second peak at 84 days of pressure overload (+60%, P<0.05), at the later time point in conjunction with elevated ECE-1 mRNA levels (+20%, P<0.05). The functional implications of ET-1 were examined in a study of isolated perfused hearts. Both hearts with established LVH and sham control hearts responded to ET-1 perfusion (10-(11) to 10(-9) M) with an increase of coronary perfusion pressure (CPP; +85+/-15 and +75+/-8 mmHg; P<0.001 each) and a slight decrease of LV systolic pressure (LVP; -12+/-9 and -9+/-7 mmHg; P=NS). In contrast, ET-1 increased LV end-diastolic pressure (LVEDP) only in LVH hearts (+22+/-7 mmHg, P<0.05 versus baseline and +20 +/-7 mmHg, P<0.05 versus sham). Direct stimulation of protein kinase C mimicked the effects of ET-1, whereas inhibition of this kinase or the Na+-H+ exchanger blunted the effects of ET-1 on CPP, LVP, and LVEDP. Interestingly, coadministration of the vasodilator and the nitric oxide (NO) donor nitroglycerin not only prevented the increase of CPP and LVEDP, but also uncovered a slight positive inotropic effect of ET-1 in LVH hearts. Thus, the cardiac expression of ET-1, ETA, and ECE-1 mRNAs displays a distinct pattern during early and advanced cardiac pressure overload. Furthermore, ET-1 mediates a slight depression of systolic, and a profound depression of diastolic, functional parameters in hearts with established LVH, effects that appear to be secondary to ET-1-related coronary vasoconstriction. The data suggest a functional role of the endothelin system in hearts with established pressure overload hypertrophy.
引用
收藏
页码:623 / 630
页数:8
相关论文
共 30 条
[11]   Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart [J].
Kobayashi, T ;
Miyauchi, T ;
Sakai, S ;
Kobayashi, M ;
Yamaguchi, I ;
Goto, K ;
Sugishita, Y .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (04) :H1197-H1206
[12]  
KRAMER B, 1991, CIRC RES, V98, P269
[13]   ENDOTHELINS - MYOCARDIAL ACTIONS OF A NEW CLASS OF CYTOKINES [J].
KRAMER, BK ;
NISHIDA, M ;
KELLY, RA ;
SMITH, TW .
CIRCULATION, 1992, 85 (01) :350-356
[14]   Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II [J].
Maki, S ;
Miyauchi, T ;
Sakai, S ;
Kobayashi, T ;
Maeda, S ;
Takata, Y ;
Sugiyama, F ;
Fukamizu, A ;
Murakami, K ;
Goto, K ;
Sugishita, Y .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 31 :S412-S416
[15]   Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis [J].
Minamino, T ;
Kurihara, H ;
Takahashi, M ;
Shimada, K ;
Maemura, K ;
Oda, H ;
Ishikawa, T ;
Uchiyama, T ;
Tanzawa, K ;
Yazaki, Y .
CIRCULATION, 1997, 95 (01) :221-230
[16]   INDUCTION OF IMMEDIATE-EARLY GENES BY ANGIOTENSIN-H AND ENDOTHELIN-1 IN ADULT-RAT CARDIOMYOCYTES [J].
NEYSES, L ;
NOUSKAS, J ;
LUYKEN, J ;
FRONHOFFS, S ;
OBERDORF, S ;
PFEIFER, U ;
WILLIAMS, RS ;
SUKHATME, VP ;
VETTER, H .
JOURNAL OF HYPERTENSION, 1993, 11 (09) :927-934
[17]   MODULATION OF SYSTOLIC AND DIASTOLIC FUNCTION BY ENDOTHELIN-1 - RELATION TO CORONARY FLOW [J].
OFFSTAD, J ;
TONNESSEN, T ;
KIRKEBOEN, KA ;
ILEBEKK, A ;
DOWNING, SE .
ACTA PHYSIOLOGICA SCANDINAVICA, 1995, 154 (02) :103-111
[18]   CHARACTERIZATION AND FUNCTIONAL-ANALYSIS OF THE RAT ENDOTHELIN-1 PROMOTER [J].
PAUL, M ;
ZINTZ, M ;
BOCKER, W ;
DYER, M .
HYPERTENSION, 1995, 25 (04) :683-687
[19]   Endothelin receptors in the failing and nonfailing human heart [J].
Pönicke, K ;
Vogelsang, M ;
Heinroth, M ;
Becker, K ;
Zolk, O ;
Böhm, M ;
Zerkowski, HR ;
Brodde, OE .
CIRCULATION, 1998, 97 (08) :744-751
[20]   Inhibition of myocardial endothelin pathway improves long-term survival in heart failure [J].
Sakai, S ;
Miyauchi, T ;
Kobayashi, M ;
Yamaguchi, I ;
Goto, K ;
Sugishita, Y .
NATURE, 1996, 384 (6607) :353-355